David R. Guyer MD

David Guyer, M.D. is a co-founder and Executive Chairman of our company. Dr Guyer served as Chairman of our board of directors since our inception in January 2007 to January 2017 and as our Chief Executive Officer from April 2013 to January 2017. Prior to serving as our Chief Executive Officer, Dr. Guyer, served as a Partner at SV Life Sciences Advisers, LLC, a venture capital firm, from 2009 to 2013, and as a Venture Partner at SV Life Sciences from 2006 to 2009. In April 2013, Dr Guyer resumed his role as Venture Partner at SV Life Sciences. He currently serves on the board of directors of Thrombogenics NV, which is a publicly-traded biotechnology company. Dr Guyer co-founded Eyetech Pharmaceuticals Inc. and served as its Chief Executive Officer and as a member of its board of directors from 2000 until it was acquired by OSI Pharmaceuticals, Inc. in November 2005. Prior to co-founding Eyetech Pharmaceuticals, Dr Guyer was a Professor and served as Chairman of the Department of Ophthalmology at New York University School of Medicine. Dr Guyer received a B.S. from Yale College and an M.D. from Johns Hopkins Medical School. Dr Guyer completed his ophthalmology residency at Wilmer Ophthalmological Institute, Johns Hopkins Hospital and a retinal fellowship at the Massachusetts Eye and Ear Infirmary at Harvard Medical School.